Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia

Thomas C.C. Boerlage; Charlotte L.E. van Hees; Alwin D.R. Huitema; Fanny N. Lauw

doi:10.1007/s11695-015-2020-0

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia

Thomas C.C. Boerlage, Charlotte L.E. van Hees, Alwin D.R. Huitema, Fanny N. Lauw

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

3 Citaten (Scopus)

Samenvatting

Proton pump inhibitor (PPI)-induced hypomagnesemia is currently a major topic. Patients undergoing Roux-en-Y gastric bypass are generally prescribed PPI prophylaxis after surgery. We investigated the prevalence of hypomagnesemia in our bariatric population. We reviewed the files of 1000 postoperative patients for serum magnesium level during PPI use. We found only five cases of hypomagnesemia, none of which was evidently related to PPI use. We conclude that the risk of hypomagnesemia during 1 year of prophylactic PPI use after Roux-en-Y gastric bypass (RYGB) is minimal and laboratory screening is probably not necessary.

Originele taal-2	Engels
Pagina's (van-tot)	688-690
Aantal pagina's	3
Tijdschrift	Obesity Surgery
Volume	26
Nummer van het tijdschrift	3
DOI's	https://doi.org/10.1007/s11695-015-2020-0
Status	Gepubliceerd - 1 mrt. 2016
Extern gepubliceerd	Ja

Toegang tot document

10.1007/s11695-015-2020-0

Citeer dit

@article{340bf95b485a4e56880c4aa6423ac045,

title = "Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia",

abstract = "Proton pump inhibitor (PPI)-induced hypomagnesemia is currently a major topic. Patients undergoing Roux-en-Y gastric bypass are generally prescribed PPI prophylaxis after surgery. We investigated the prevalence of hypomagnesemia in our bariatric population. We reviewed the files of 1000 postoperative patients for serum magnesium level during PPI use. We found only five cases of hypomagnesemia, none of which was evidently related to PPI use. We conclude that the risk of hypomagnesemia during 1 year of prophylactic PPI use after Roux-en-Y gastric bypass (RYGB) is minimal and laboratory screening is probably not necessary.",

keywords = "Gastric bypass, Hypomagnesemia, Proton pump inhibitor",

author = "Boerlage, {Thomas C.C.} and {van Hees}, {Charlotte L.E.} and Huitema, {Alwin D.R.} and Lauw, {Fanny N.}",

note = "Publisher Copyright: {\textcopyright} 2016, The Author(s).",

year = "2016",

month = mar,

day = "1",

doi = "10.1007/s11695-015-2020-0",

language = "English",

volume = "26",

pages = "688--690",

journal = "Obesity Surgery",

issn = "0960-8923",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia

AU - Boerlage, Thomas C.C.

AU - van Hees, Charlotte L.E.

AU - Huitema, Alwin D.R.

AU - Lauw, Fanny N.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Proton pump inhibitor (PPI)-induced hypomagnesemia is currently a major topic. Patients undergoing Roux-en-Y gastric bypass are generally prescribed PPI prophylaxis after surgery. We investigated the prevalence of hypomagnesemia in our bariatric population. We reviewed the files of 1000 postoperative patients for serum magnesium level during PPI use. We found only five cases of hypomagnesemia, none of which was evidently related to PPI use. We conclude that the risk of hypomagnesemia during 1 year of prophylactic PPI use after Roux-en-Y gastric bypass (RYGB) is minimal and laboratory screening is probably not necessary.

AB - Proton pump inhibitor (PPI)-induced hypomagnesemia is currently a major topic. Patients undergoing Roux-en-Y gastric bypass are generally prescribed PPI prophylaxis after surgery. We investigated the prevalence of hypomagnesemia in our bariatric population. We reviewed the files of 1000 postoperative patients for serum magnesium level during PPI use. We found only five cases of hypomagnesemia, none of which was evidently related to PPI use. We conclude that the risk of hypomagnesemia during 1 year of prophylactic PPI use after Roux-en-Y gastric bypass (RYGB) is minimal and laboratory screening is probably not necessary.

KW - Gastric bypass

KW - Hypomagnesemia

KW - Proton pump inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84959083560&partnerID=8YFLogxK

U2 - 10.1007/s11695-015-2020-0

DO - 10.1007/s11695-015-2020-0

M3 - Article

C2 - 26762281

AN - SCOPUS:84959083560

SN - 0960-8923

VL - 26

SP - 688

EP - 690

JO - Obesity Surgery

JF - Obesity Surgery

IS - 3

ER -

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit